Correlation Between Cadrenal Therapeutics, and Vaccinex

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Cadrenal Therapeutics, and Vaccinex at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Cadrenal Therapeutics, and Vaccinex into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Cadrenal Therapeutics, Common and Vaccinex, you can compare the effects of market volatilities on Cadrenal Therapeutics, and Vaccinex and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Cadrenal Therapeutics, with a short position of Vaccinex. Check out your portfolio center. Please also check ongoing floating volatility patterns of Cadrenal Therapeutics, and Vaccinex.

Diversification Opportunities for Cadrenal Therapeutics, and Vaccinex

-0.7
  Correlation Coefficient

Excellent diversification

The 3 months correlation between Cadrenal and Vaccinex is -0.7. Overlapping area represents the amount of risk that can be diversified away by holding Cadrenal Therapeutics, Common and Vaccinex in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Vaccinex and Cadrenal Therapeutics, is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Cadrenal Therapeutics, Common are associated (or correlated) with Vaccinex. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Vaccinex has no effect on the direction of Cadrenal Therapeutics, i.e., Cadrenal Therapeutics, and Vaccinex go up and down completely randomly.

Pair Corralation between Cadrenal Therapeutics, and Vaccinex

Given the investment horizon of 90 days Cadrenal Therapeutics, Common is expected to under-perform the Vaccinex. But the stock apears to be less risky and, when comparing its historical volatility, Cadrenal Therapeutics, Common is 1.35 times less risky than Vaccinex. The stock trades about -0.03 of its potential returns per unit of risk. The Vaccinex is currently generating about 0.04 of returns per unit of risk over similar time horizon. If you would invest  374.00  in Vaccinex on August 29, 2024 and sell it today you would lose (5.00) from holding Vaccinex or give up 1.34% of portfolio value over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthWeak
Accuracy100.0%
ValuesDaily Returns

Cadrenal Therapeutics, Common  vs.  Vaccinex

 Performance 
       Timeline  
Cadrenal Therapeutics, 

Risk-Adjusted Performance

12 of 100

 
Weak
 
Strong
Good
Compared to the overall equity markets, risk-adjusted returns on investments in Cadrenal Therapeutics, Common are ranked lower than 12 (%) of all global equities and portfolios over the last 90 days. In spite of rather unfluctuating forward-looking signals, Cadrenal Therapeutics, exhibited solid returns over the last few months and may actually be approaching a breakup point.
Vaccinex 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Vaccinex has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of unfluctuating performance in the last few months, the Stock's basic indicators remain fairly strong which may send shares a bit higher in December 2024. The current disturbance may also be a sign of long term up-swing for the company investors.

Cadrenal Therapeutics, and Vaccinex Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Cadrenal Therapeutics, and Vaccinex

The main advantage of trading using opposite Cadrenal Therapeutics, and Vaccinex positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Cadrenal Therapeutics, position performs unexpectedly, Vaccinex can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Vaccinex will offset losses from the drop in Vaccinex's long position.
The idea behind Cadrenal Therapeutics, Common and Vaccinex pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Piotroski F Score module to get Piotroski F Score based on the binary analysis strategy of nine different fundamentals.

Other Complementary Tools

AI Portfolio Architect
Use AI to generate optimal portfolios and find profitable investment opportunities
Cryptocurrency Center
Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency
Balance Of Power
Check stock momentum by analyzing Balance Of Power indicator and other technical ratios
Portfolio Diagnostics
Use generated alerts and portfolio events aggregator to diagnose current holdings
Content Syndication
Quickly integrate customizable finance content to your own investment portal